• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Biotechnology Portfolio

+ Add to Watchlist

FBIOX:US

218.90 USD 2.26 1.04%

As of 09:29:30 ET on 08/29/2014.

Snapshot for Fidelity Select Biotechnology Portfolio (FBIOX)

Year To Date: +20.45% 3-Month: +17.39% 3-Year: +44.30% 52-Week Range: 159.44 - 228.64
1-Month: +13.17% 1-Year: +36.14% 5-Year: +29.47% Beta vs MXWO: 1.08

Mutual Fund Chart for FBIOX

No chart data available.
  • FBIOX:US 218.90
  • 1M
  • 1Y
Interactive FBIOX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBIOX

Fidelity Select Biotechnology Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-16-1985 Telephone: 1-800-544-6666
Managers: RAJIV KAUL
Web Site: www.fidelity.com

Fundamentals for FBIOX

NAV (on 2014-08-29) 218.90
Assets (M) (on 2014-07-31) 8,218.95
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBIOX

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) 0.19

Fees & Expenses for FBIOX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.75

Top Fund Holdings for FBIOX

Filing Date: 06/30/2014
Name Position Value % of Total
Gilead Sciences Inc 13,536,085 1,122,276,807 12.973%
Biogen Idec Inc 1,450,287 457,289,994 5.286%
Vertex Pharmaceuticals Inc 4,580,787 433,708,913 5.013%
Amgen Inc 3,465,448 410,205,080 4.742%
Intercept Pharmaceuticals Inc 1,162,568 275,098,466 3.180%
InterMune Inc 5,286,810 233,412,662 2.698%
Medivation Inc 2,433,685 187,588,440 2.168%
Alexion Pharmaceuticals Inc 976,980 152,653,125 1.765%
Celgene Corp 1,745,912 149,938,923 1.733%
BioMarin Pharmaceutical Inc 2,328,644 144,864,943 1.675%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil